Emerald Bioventures
Life-sciences focused incubator and venture studio that forms, funds, and scales healthcare and biotech companies. Activities include ideation and company formation, capital advisory and fundraising, portfolio management, operational support for clinical and digital health ventures, and support for translational research and early clinical development.
Industries
N/A
Nr. of Employees
small (1-50)
Emerald Bioventures
Products
Aikium
Portfolio company listed on the portfolio page.
Avalo Therapeutics
Portfolio company listed on the portfolio page.
BIOS
Portfolio company listed on the portfolio page.
Bond Biosciences
Portfolio company listed on the portfolio page.
eGlint
Digital health portfolio company listed on the portfolio page.
Flame Biosciences (founded and exited)
Inflammasome-focused therapeutics company founded by Emerald and subsequently acquired.
Aikium
Portfolio company listed on the portfolio page.
Avalo Therapeutics
Portfolio company listed on the portfolio page.
BIOS
Portfolio company listed on the portfolio page.
Bond Biosciences
Portfolio company listed on the portfolio page.
eGlint
Digital health portfolio company listed on the portfolio page.
Flame Biosciences (founded and exited)
Inflammasome-focused therapeutics company founded by Emerald and subsequently acquired.
Services
Ideation, company formation, operational support and go-to-market planning for life sciences and healthcare startups.
Advisory on capital raising, deal structuring, sourcing investors and supporting exit transactions.
Operationalizing specialty clinics, deploying digital health platforms, and integrating telehealth, e-prescribing and patient management systems.
Ideation, company formation, operational support and go-to-market planning for life sciences and healthcare startups.
Advisory on capital raising, deal structuring, sourcing investors and supporting exit transactions.
Operationalizing specialty clinics, deploying digital health platforms, and integrating telehealth, e-prescribing and patient management systems.
Expertise Areas
- Venture formation and startup incubation
- Digital health and telemedicine platforms
- Proteomics and biomarker discovery
- Genetic association studies and translational genomics
Key Technologies
- Proteomics
- Genomic analysis (GWAS, whole-exome sequencing)
- Telemedicine platforms (HIPAA-compliant)
- E-prescribing and pharmacy fulfillment integration
News & Updates
Announcement referencing inclusion of a portfolio company in an accelerator cohort.
Review summarizing recent genetic and mechanistic advances in hyperemesis gravidarum research, including the role of GDF15 and implications for prevention and treatment.
Coverage of the opening of a specialty clinic for severe pregnancy nausea/vomiting and description of clinic services and research plans.
Fast Company profile of a specialty clinic and its founders focused on hyperemesis gravidarum, describing services and research aims.
Profile of a researcher whose genetic discoveries on severe morning sickness informed the launch of a specialty clinic and research platform.
Report on the opening of a clinic offering infusion, medication management, diagnostic testing and plans to run clinical trials for new treatments.
Announcement referencing inclusion of a portfolio company in an accelerator cohort.
Review summarizing recent genetic and mechanistic advances in hyperemesis gravidarum research, including the role of GDF15 and implications for prevention and treatment.
Coverage of the opening of a specialty clinic for severe pregnancy nausea/vomiting and description of clinic services and research plans.
Fast Company profile of a specialty clinic and its founders focused on hyperemesis gravidarum, describing services and research aims.
Profile of a researcher whose genetic discoveries on severe morning sickness informed the launch of a specialty clinic and research platform.
Report on the opening of a clinic offering infusion, medication management, diagnostic testing and plans to run clinical trials for new treatments.